Showing results (51-60 of 177) with videos related to
Sort By:
Pageof 18
Biomaterials|July 1, 1987
Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextransB Crepon, F Maillet, M D Kazatchkine, et al.Journal of Cellular Physiology|January 1, 1992
Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFM Tardieu, C Gamby, T Avramoglou, et al.Biomaterials|May 1, 1985
Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivationA M Fischer, M Mauzac, J Tapon-Bretaudiere, et al.Journal of Medical Genetics|June 5, 2001
Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinomaS Olschwang, C Boisson, G ThomasJournal of Chromatography|June 27, 1990
High-performance affinity chromatography of basic fibroblast growth factor on polystyrene sulphonate resins modified with serineM A Jacquot-Dourges, D Muller, D Barritault, et al.Biomaterials|March 1, 1996
Relationships between chemical characteristics and anticomplementary activity of fucansC Blondin, F Chaubet, A Nardella, et al.Biomaterials|August 1, 1991
Enzymatic degradation and immunogenic properties of derivatized dextransB Crepon, J Jozefonvicz, V Chytry, et al.Biomaterials|August 1, 1989
New natural polysaccharides with potent antithrombic activity: fucans from brown algaeV Grauffel, B Kloareg, S Mabeau, et al.Journal of Biomaterials Science. Polymer Edition|January 1, 1994
Effect of a derivatized dextran on human osteoblast growth and phenotype expressionS Berrada, J Amedee, T Avramoglou, et al.Journal of Chromatography|February 22, 1991
Affinity chromatography of fibroblast growth factors on coated silica supports grafted with heparinM A Jacquot-Dourges, F L Zhou, D Muller, et al.Pageof 18